{
    "organizations": [],
    "uuid": "15a550b5a8053063b625e99a26f085131ee0abaa",
    "author": "",
    "url": "https://www.reuters.com/article/brief-fate-therapeutics-announces-additi/brief-fate-therapeutics-announces-additional-clinical-data-from-phase-1-stage-of-protect-clinical-trial-of-protmune-idUSASC09SRJ",
    "ord_in_thread": 0,
    "title": "BRIEF-Fate Therapeutics Announces Additional Clinical Data From Phase 1 Stage Of Protect Clinical Trial Of Protmune",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 19, 2018 / 12:28 PM / Updated 8 minutes ago BRIEF-Fate Therapeutics Announces Additional Clinical Data From Phase 1 Stage Of Protect Clinical Trial Of Protmune Reuters Staff 1 Min Read March 19 (Reuters) - Fate Therapeutics Inc: * FATE THERAPEUTICS ANNOUNCES ADDITIONAL CLINICAL DATA FROM PHASE 1 STAGE OF PROTECT CLINICAL TRIAL OF PROTMUNE™ * FATE THERAPEUTICS INC - ‍NO EVENTS OF CANCER RELAPSE HAVE OCCURRED WITH PROTMUNE IN PHASE 1 STAGE OF PROTECT​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-19T14:27:00.000+02:00",
    "crawled": "2018-03-19T14:38:45.007+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "pm",
        "updated",
        "minute",
        "ago",
        "therapeutic",
        "announces",
        "additional",
        "clinical",
        "data",
        "phase",
        "stage",
        "protect",
        "clinical",
        "trial",
        "protmune",
        "reuters",
        "staff",
        "min",
        "read",
        "march",
        "reuters",
        "fate",
        "therapeutic",
        "inc",
        "fate",
        "therapeutic",
        "announces",
        "additional",
        "clinical",
        "data",
        "phase",
        "stage",
        "protect",
        "clinical",
        "trial",
        "fate",
        "therapeutic",
        "inc",
        "event",
        "cancer",
        "relapse",
        "occurred",
        "protmune",
        "phase",
        "stage",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}